U.S. Markets open in 36 mins.

Aratana Therapeutics, Inc. (PETX)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
5.47-0.05 (-0.91%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue38,551678767
Cost of Revenue3,139365333
Gross Profit35,412313434
Operating Expenses
Research Development30,46224,96419,985
Selling General and Administrative27,34219,81917,938
Non Recurring8,04843,4822,229
Total Operating Expenses66,23189,80942,043
Operating Income or Loss-30,819-89,496-41,609
Income from Continuing Operations
Total Other Income/Expenses Net6405,3292,410
Earnings Before Interest and Taxes-30,179-84,167-39,199
Interest Expense3,3961,5851,060
Income Before Tax-33,575-85,752-40,259
Income Tax Expense--1,698-1,443
Minority Interest---
Net Income From Continuing Ops-33,575-84,054-38,816
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-33,575-84,054-38,816
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-33,575-84,054-38,816